2A Pharma AB is a Swedish AB based in Limhamn, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2016, the company has 0 employees and reported revenue of −1 kr in its latest annual filing.
Firman tecknas av styrelsen Firman tecknas av Bruun-Nyzell, Preben i förening med en av ledamöterna Firman tecknas av Lainevool, Peter Christian i förening med en av ledamöterna Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva forskning, utveckling och kommersialisering av läkemedel samt därmed förenlig verksamhet.
In its most recent annual report (2025), 2A Pharma AB reported revenue of −1 kr. The figures on this page draw on 5 annual filings covering 2021 to 2025. The bottom line showed a net loss of 3,0 mn kr.
At the end of 2025, equity financed 29.2% of the balance sheet, and current assets covered short-term debt 0.1 times.
Frequently asked questions
What is the Org number of 2A Pharma AB?
2A Pharma AB is registered with Bolagsverket / SCB under Org 5590902788.
What is the revenue of 2A Pharma AB?
2A Pharma AB reported revenue of −1 kr in 2025.
Who is the CEO of 2A Pharma AB?
Preben Bruun-Nyzell is the CEO of 2A Pharma AB, in role since 2020.
Who is the chairman of 2A Pharma AB?
Peter Christian Lainevool chairs the board of 2A Pharma AB, in role since 2020.
Where is 2A Pharma AB headquartered?
2A Pharma AB's registered address is Båtbyggaregatan 44.
